These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 17936)

  • 21. Plasminogen activator (urokinase) from cultured cells.
    Lewis LJ
    Thromb Haemost; 1979 Oct; 42(3):895-900. PubMed ID: 505404
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Morphology and aggregative properties of erythrocytes in patients with hemorrhagic fever with nephrotic syndrome].
    Davidovich IM
    Ter Arkh; 1989; 61(2):70-2. PubMed ID: 2567064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical characteristics of hemorrhagic fever with nephrotic syndrome in young patients].
    Mironov GS
    Klin Med (Mosk); 1979 Feb; 57(2):45-9. PubMed ID: 34057
    [No Abstract]   [Full Text] [Related]  

  • 24. Alteration of polypeptide backbone structure as determined by circular dichroic spectral analysis in relation to change of plasminogen activator activity of two forms of human urinary urokinase denatured with guanidine hydrochloride.
    Miwa N; Yamashita A; Suzuki A
    Chem Pharm Bull (Tokyo); 1982 Oct; 30(10):3669-78. PubMed ID: 6761000
    [No Abstract]   [Full Text] [Related]  

  • 25. [Arterial hypertension, central and renal hemodynamics and plasma renin activity in patients with hemorrhagic fever and renal syndrome].
    Sirotin BZ; Zaev AP; Bystrovskiĭ VF
    Klin Med (Mosk); 1978 Sep; 56(9):68-73. PubMed ID: 29987
    [No Abstract]   [Full Text] [Related]  

  • 26. Isoelectric points of two molecular forms of human urinary urokinase determined by density-gradient isoelectric focusing and isotachoelectrophoresis.
    Miwa N; Sawada T; Suzuki A
    Chem Pharm Bull (Tokyo); 1982 Apr; 30(4):1513-6. PubMed ID: 7049421
    [No Abstract]   [Full Text] [Related]  

  • 27. [Disruption of the balance of amino acids in patients with hemorrhagic fever with kidney syndrome].
    Sidel'nikov IuN; Obukhova GG
    Vopr Med Khim; 1994; 40(1):44-7. PubMed ID: 7907199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Proteins and protein complexes in urine of patients with hemorrhagic fever with nephrotic syndrome].
    Starostina IS; Koval'skiĭ GS
    Klin Med (Mosk); 1975 Apr; 53(4):102-7. PubMed ID: 1152356
    [No Abstract]   [Full Text] [Related]  

  • 29. [Various indicators of central and renal hemodynamics in patients with history of hemorrhagic fever with nephrotic syndrome].
    Sirotin BZ; Zaev AP
    Ter Arkh; 1978; 50(6):73-5. PubMed ID: 27874
    [No Abstract]   [Full Text] [Related]  

  • 30. Spectrometric determination of urokinase in urine after gel filtration, using the chromogenic substrate S-2444.
    Paar D; Maruhn D
    J Clin Chem Clin Biochem; 1980 Sep; 18(9):557-62. PubMed ID: 7003055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hemodialysis in patients with acute renal insufficiency in hemorrhagic fever with nephrotic syndrome].
    Zagidullin IM; Sakaeva MF
    Klin Med (Mosk); 1983 Aug; 61(8):105-7. PubMed ID: 6139504
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparative studies on two active enzyme forms of human urinary urokinase. I. Purification by serial column chromatography and homogeneity analyses of molecular weight and isoelectric point.
    Miwa N; Takayanagi H; Suzuki A
    Chem Pharm Bull (Tokyo); 1981 Feb; 29(2):463-71. PubMed ID: 7023709
    [No Abstract]   [Full Text] [Related]  

  • 33. Tyrosyl residues of two molecular forms of human urinary urokinase: their ionization mode characterized by spectrophotometric and CD titrations and reactivity with cyanuric fluoride in relation to enzymic activity.
    Miwa N; Sawada T; Suzuki A
    Biochem Biophys Res Commun; 1982 Oct; 108(3):1136-43. PubMed ID: 6758771
    [No Abstract]   [Full Text] [Related]  

  • 34. [Nephrogenic hypertension in patients with a history of hemorrhagic fever with nephrotic syndrome].
    Sirotin BZ; Lobastova GS; Sirotina ZV
    Klin Med (Mosk); 1979 Feb; 57(2):41-5. PubMed ID: 34056
    [No Abstract]   [Full Text] [Related]  

  • 35. [Isolation and purification of urokinase].
    Kol'tsova SV; Shataeva LK; Sukhareva TF; Byniaeva NA; Fedorova ZD
    Vopr Med Khim; 1981; 27(5):623-6. PubMed ID: 7032062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Acute renal insufficiency in hemorrhagic fever with nephrotic syndrome].
    Mazin VV; Olofinskiĭ LA; Ryzhenko VM; Shakin VM; Meshcheriakova RI
    Ter Arkh; 1978; 50(6):86-9. PubMed ID: 27875
    [No Abstract]   [Full Text] [Related]  

  • 37. [Hemorrhagic fever with nephrotic syndrome].
    Detsik IuI; Leont'eva MP; Novitskiĭ IaD
    Vrach Delo; 1980 Jun; (6):20-2. PubMed ID: 6105742
    [No Abstract]   [Full Text] [Related]  

  • 38. [Outcome of antibiotic therapy in patients with hemorrhagic fever with renal syndrome].
    Sidel'nikov IuN; Martynenko AIu
    Ter Arkh; 2001; 73(11):78-81. PubMed ID: 11806215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kinetics of the inhibition by plasminogen activator inhibitor 2 of urokinase isolated from human urine and recombinant microorganisms. Further evidence for correct tertiary structure of recombinant urokinase.
    Cramer J; Steffens G; Günzler WA; Hess V; Flohé L
    Arzneimittelforschung; 1988 Aug; 38(8):1196-8. PubMed ID: 3143371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasminogen activation activity of urokinase determined via a cascade enzymatic reaction system.
    Lee WC; Chuang CY; Chang RM
    Biochem Mol Biol Int; 1993 Apr; 29(6):1039-46. PubMed ID: 8330012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.